ASND
Ascendis Pharma·NASDAQ
--
--(--)
--
--(--)
ASND fundamentals
Ascendis Pharma (ASND) expects to report earnings on Feb 11, 2026, with estimated revenue of 288.45M (YoY +60.21%), and EPS at -0.2246 (YoY +66.10%).
Revenue estimate / YoY
288.45M
+60.21%
EPS estimate / YoY
-0.2246
+66.10%
Report date
Feb 11, 2026
Earnings Call
4:30 PM on Feb 11, 2026
Meeting link.EPS
Revenue
Revenue & Expenses
ASND has released its 2025 Q3 earnings report, with revenue of 250.70M, reflecting a YoY change of 288.95%, and net profit of -71.57M, showing a YoY change of 35.26%. The Sankey diagram below clearly presents ASND's revenue sources and cost distribution.
Key Indicators
Ascendis Pharma (ASND) key financial stats and ratios, covering profitability, financial health, and leverage.
Ascendis Pharma (ASND)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Ascendis Pharma (ASND)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Ascendis Pharma (ASND)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Ascendis Pharma (ASND) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Ascendis Pharma (ASND) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Ascendis Pharma's management provide for the next earnings period?What factors drove the changes in Ascendis Pharma's revenue and profit?What is Ascendis Pharma's gross profit margin?What is the revenue and EPS growth rate for Ascendis Pharma year over year?What were the key takeaways from Ascendis Pharma’s earnings call?Did Ascendis Pharma beat or miss consensus estimates last quarter?What were the key takeaways from Ascendis Pharma's earnings call?What does Ascendis Pharma do and what are its main business segments?
